1429-06-7

Basic information

• Product Name: 5B-Androstane-3,11,17-trione
• Synonyms: 5B-Androstane-3,11,17-trione
• CAS NO: 1429-06-7
• Molecular Formula: C₁₉H₂₆O₃
• Molecular Weight: 302.41
• Mol File: 1429-06-7.mol
• Article Data: 11

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5B-Androstane-3,11,17-trione(CAS DataBase Reference)
• NIST Chemistry Reference: 5B-Androstane-3,11,17-trione(1429-06-7)
• EPA Substance Registry System: 5B-Androstane-3,11,17-trione(1429-06-7)

Safety Data

• Hazardous Substances Data: 1429-06-7(Hazardous Substances Data)

Upstream product

• 7090-90-6 3β-hydroxy-5α-androstane-11,17-dione 
• 382-45-6 adrenosterone 
• 57-61-4 (3R,5S,8S,9S,10S,11S,13S,14S)-3,11-dihydroxy-10,13-dimethyl-tetradecahydro-2H-cyclopenta[a]phenanthren-17(14H)-one 
• 25788-56-1 11α,17β-dihydroxy-5α-androstan-3-one 
• 32326-39-9 3β,11α,17β-trihydroxy-5α-androstane 
• 599-11-1 11β-hydroxyandrostenedione 
• 64-19-7 acetic acid 
• 302-91-0 3α,11β,17α,21-tetrahydroxy-5α-pregnan-20-one 
• 514-17-0 3β,11β-dihydroxy-5α-androstan-17-one 
• 651-43-4 5α-pregnane-3β,11β,17α,21-tetraol-20-one 
• 516-45-0 3β,17,21-trihydroxy-5α-pregnane-11,20-dione 
• 516-39-2 5α-pregnane-3β,11β,17,20β_F,21-pentaol 
• 67-64-1 acetone 
• 7664-93-9 sulfuric acid 

Downstream Products

• 1755-32-4 5αH-androstan-11-one 
• 32693-29-1 3β,16β-Dihydroxy-5α-androstan-11-on 
• 894-64-4 5β-androstan-11-one 
• 1231-82-9 (3α,5α)-3-hydroxyandrostane-11,17-dione 
• 438-22-2 (5α)-androstane 
• 15375-19-6 (5α)-androst-9(11)-ene-3,17-dione 
• 124071-37-0 3α-(dimethylphenylsiloxy)-5α-androstane-11,17-dione 
• 140902-28-9 3α-(dimethylphenylsiloxy)-17α-hydroxy-5α-androstan-11-one 
• 124071-38-1 3α-(dimethylphenylsiloxy)-17β-hydroxy-5α-androstan-11-one 
• 124151-22-0 3α-(dimethylphenylsiloxy)-5α,13α-androstane-11,17-dione 
• 7738-93-4 androsta-1,4-diene-3,11,17-trione 
• 564-35-2 11-ketotestosterone 

Relevant articles and documents

OXYSTEROLS AND METHODS OF USE THEREOF

Compounds are provided according to Formula (A): and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein R1, R2, R3, R4, R5, R6, and RG are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of conditions.

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

Described herein are neuroactive steroids of the Formula (I): or a pharmaceutically acceptable salt thereof; wherein (II), A, R1, R2, R3a, R4a, R4b, R5, R7a, and R7b are as defined herein. Such compounds are envisioned, in certain embodiments, to behave as GABA modulators. The present invention also provides pharmaceutical compositions comprising a compound of the present invention and methods of use and treatment, e.g., such for inducing sedation and/or anesthesia.

Antenna-initiated photochemistry of distal groups in polyfunctional steroids. Intramolecular singlet and triplet energy transfer in 3α-(dimethylphenylsiloxy)-5α-androstan-17-one and 3α-(dimethylphenylsiloxy)-5α-androstane-11,17-dione

-